Piramal Pharma to acquire 100% stake in Hemmo Pharma for ₹775 crore
Through Hemmo Pharma, Piramal Pharma Solutions will gain access to the growing peptide API market and enhance its ability to offer integrated services to its customers globally
Through Hemmo Pharma, Piramal Pharma Solutions will gain access to the growing peptide API market and enhance its ability to offer integrated services to its customers globally
0 Comments
Post a Comment